(Q48477314)

11 February 2018

title

The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study (English)

1 reference

11 February 2018

0 references

Maureen Lacy

1

1 reference

11 February 2018

Meagan Hauser

2

1 reference

11 February 2018

Neil Pliskin

3

1 reference

11 February 2018

Stephanie Assuras

4

1 reference

11 February 2018

Mildred O Valentine

5

1 reference

11 February 2018

Anthony Reder

6

1 reference

11 February 2018

publication date

7 May 2013

1 reference

11 February 2018

Multiple Sclerosis Journal

published in

1 reference

11 February 2018

volume

19

1 reference

11 February 2018

issue

13

1 reference

11 February 2018

page(s)

1765-1772

1 reference

11 February 2018

Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Cognitive deterioration in patients with early multiple sclerosis: a 5-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Interferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Effect of interferon-beta-1b on cognitive functions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

The role of inflammation in the pathogenesis of delirium and dementia in older adults: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513485981

21 January 2018

Identifiers

DOI

10.1177/1352458513485981

1 reference

11 February 2018

1 reference

11 February 2018